{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:24:06Z","timestamp":1794266646357,"version":"4.9.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T00:00:00Z","timestamp":1763251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T00:00:00Z","timestamp":1763251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Basic Clin. Androl."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women with potential familial and genetic components. Emerging evidence suggests that male first-degree relatives (fathers and brothers) may exhibit endocrine and metabolic abnormalities similar to a \u201cmale equivalent\u201d of PCOS, although the condition remains without clear diagnostic criteria. We conducted a systematic review and meta-analysis to investigate whether male relatives of women with PCOS show consistent patterns of metabolic and hormonal dysregulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 21 studies met inclusion criteria, encompassing male first-degree relatives of women with PCOS with available data on metabolic, hormonal, and cardiovascular outcomes. Meta-analysis showed that male relatives had significantly higher fasting blood glucose (MD: 6.25; 95% CI: 1.36\u201311.14), body mass index (1.18; 0.35\u20132.02), triglycerides (17.82; 10.82\u201324.81), total cholesterol (18.63; 6.16\u201331.10), LDL-cholesterol (12.99; 1.27\u201324.71), and dehydroepiandrosterone sulfate (1.29; 0.66\u20131.92) compared with controls. They also exhibited higher prevalence of hypertension (OR: 1.88; 1.18\u20132.29), waist circumference\u2009&gt;\u200990 cm (3.27; 1.18\u20139.08), and androgenetic alopecia (1.65; 1.04\u20132.60). Findings were consistent across studies, with low to moderate heterogeneity and minimal publication bias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Male first-degree relatives of women with PCOS demonstrate increased rates of metabolic abnormalities, hormonal imbalances, and androgenic features, supporting the concept of a male PCOS of equivalent. These findings underscore the familial nature of PCOS and highlight the need for improved diagnostic criteria and higher clinical awareness. Screening male relatives for metabolic and hormonal risk factors may help identify at-risk individuals and inform preventive interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>IR.SBMU.ENDOCRINE.REC.1403.146.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12610-025-00290-1","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T17:19:26Z","timestamp":1763313566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Male polycystic ovarian syndrome phenotype: a meta-analysis of endocrine-metabolic dysregulation in fathers and brothers of PCOS-affected women"],"prefix":"10.1186","volume":"35","author":[{"given":"Kyana","family":"Jafarabady","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahryar Rajai","family":"Firouzabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fateme","family":"Mohammadifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana Mohammad","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirreza","family":"Paksaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Noroozzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4609-065X","authenticated-orcid":false,"given":"Fahimeh","family":"Ramezani Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,16]]},"reference":[{"key":"290_CR1","doi-asserted-by":"publisher","unstructured":"Wolf WM, Wattick RA, Kinkade ON, Olfert MD. Geographical prevalence of polycystic ovary syndrome as determined by region and race\/ethnicity. Int J Environ Res Public Health. 2018;15(11). https:\/\/doi.org\/10.3390\/ijerph15112589. in eng.","DOI":"10.3390\/ijerph15112589"},{"issue":"10","key":"290_CR2","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","volume":"108","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab. 2023;108(10):2447\u201369. https:\/\/doi.org\/10.1210\/clinem\/dgad463. in eng.","journal-title":"J Clin Endocrinol Metab"},{"key":"290_CR3","doi-asserted-by":"publisher","unstructured":"Hiam D et al. The genetics of polycystic ovary syndrome: an overview of candidate gene systematic reviews and genome-wide association studies. J Clin Med. 2019;8(10). https:\/\/doi.org\/10.3390\/jcm8101606. in eng.","DOI":"10.3390\/jcm8101606"},{"key":"290_CR4","doi-asserted-by":"crossref","unstructured":"Mettawi AS. Male polycystic ovary syndrome equivalent,\" in Polycystic Ovary syndrome: basic science to clinical advances across the lifespan. 2023. pp. 100\u2013110.","DOI":"10.1016\/B978-0-323-87932-3.00022-0"},{"key":"290_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mehy.2019.03.003","volume":"126","author":"F Di Guardo","year":"2019","unstructured":"Di Guardo F, Cerana MC, D\u2019Urso G, Genovese F, Palumbo M. Male PCOS equivalent and nutritional restriction: are we stepping forward? Med Hypotheses. 2019;126:1\u20133. https:\/\/doi.org\/10.1016\/j.mehy.2019.03.003.","journal-title":"Med Hypotheses"},{"issue":"12","key":"290_CR6","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1038\/s41591-019-0666-1","volume":"25","author":"S Risal","year":"2019","unstructured":"Risal S, et al. Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome. Nat Med. 2019;25(12):1894\u2013904. https:\/\/doi.org\/10.1038\/s41591-019-0666-1.","journal-title":"Nat Med"},{"key":"290_CR7","doi-asserted-by":"publisher","first-page":"1942126","DOI":"10.1155\/2020\/1942126","volume":"2020","author":"R Cannarella","year":"2020","unstructured":"Cannarella R, et al. Increased DHEAS and decreased total testosterone serum levels in a subset of men with early-onset androgenetic alopecia: does a male PCOS-equivalent exist? Int J Endocrinol. 2020;2020:1942126. https:\/\/doi.org\/10.1155\/2020\/1942126. in eng.","journal-title":"Int J Endocrinol"},{"issue":"9","key":"290_CR8","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1001\/jamadermatol.2016.1776","volume":"152","author":"S Sanke","year":"2016","unstructured":"Sanke S, Chander R, Jain A, Garg T, Yadav P. A comparison of the hormonal profile of early androgenetic alopecia in men with the phenotypic equivalent of polycystic ovarian syndrome in women. JAMA Dermatol. 2016;152(9):986\u201391. https:\/\/doi.org\/10.1001\/jamadermatol.2016.1776. in eng.","journal-title":"JAMA Dermatol"},{"key":"290_CR9","doi-asserted-by":"publisher","first-page":"1116482","DOI":"10.3389\/fendo.2023.1116482","volume":"14","author":"NM Donaldson","year":"2023","unstructured":"Donaldson NM, Prescott M, Ruddenklau A, Campbell RE, Desroziers E. Maternal androgen excess significantly impairs sexual behavior in male and female mouse offspring: perspective for a biological origin of sexual dysfunction in PCOS. Front Endocrinol. 2023;14:1116482. https:\/\/doi.org\/10.3389\/fendo.2023.1116482.","journal-title":"Front Endocrinol"},{"key":"290_CR10","doi-asserted-by":"publisher","first-page":"109601","DOI":"10.1016\/j.mehy.2020.109601","volume":"137","author":"R Cannarella","year":"2020","unstructured":"Cannarella R, La Vignera S, Barbagallo F, Condorelli RA, Calogero AE. Male polycystic ovary syndrome equivalent: a response to Di Guardo et al. Med Hypotheses. 2020;137:109601. https:\/\/doi.org\/10.1016\/j.mehy.2020.109601.","journal-title":"Med Hypotheses"},{"issue":"3","key":"290_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.33549\/physiolres.930573","volume":"53","author":"M Duskov\u00e1","year":"2004","unstructured":"Duskov\u00e1 M, Cermakova I, Hill M, Vankov\u00e1 M, S\u00e1mal\u00edkov\u00e1 P, St\u00e1rka L. What may be the markers of the male equivalent of polycystic ovary syndrome? Physiol Res. 2004;53(3):287\u201394. https:\/\/doi.org\/10.33549\/physiolres.930573.","journal-title":"Physiol Res"},{"issue":"2","key":"290_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.22074\/ijfs.2020.6092","volume":"14","author":"F Di Guardo","year":"2020","unstructured":"Di Guardo F, Ciotta L, Monteleone M, Palumbo M. Male equivalent polycystic ovarian syndrome: hormonal, metabolic, and clinical aspects. Int J Fertil Steril. 2020;14(2):79\u201383. https:\/\/doi.org\/10.22074\/ijfs.2020.6092. in eng.","journal-title":"Int J Fertil Steril"},{"issue":"1","key":"290_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s40618-017-0728-5","volume":"41","author":"R Cannarella","year":"2018","unstructured":"Cannarella R, Condorelli RA, Mongio\u00ec LM, La Vignera S, Calogero AE. Does a male polycystic ovarian syndrome equivalent exist? J Endocrinol Invest Rev. 2018;41(1):49\u201357. https:\/\/doi.org\/10.1007\/s40618-017-0728-5.","journal-title":"J Endocrinol Invest Rev"},{"key":"290_CR14","doi-asserted-by":"publisher","first-page":"263349412091303","DOI":"10.1177\/2633494120913032","volume":"14","author":"P Rao","year":"2020","unstructured":"Rao P, Bhide P. Controversies in the diagnosis of polycystic ovary syndrome. Ther Adv Reprod Health. 2020;14:2633494120913032. https:\/\/doi.org\/10.1177\/2633494120913032. in eng.","journal-title":"Ther Adv Reprod Health"},{"key":"290_CR15","unstructured":"Duskov\u00e1 M, St\u00e1rka L. The existence of a male equivalent of the polycystic ovary syndrome--the present state of the issue. Prague medical report, Review. 2006;107(1):17\u201325. [Online]. Available: https:\/\/www.scopus.com\/inward\/record.uri?eid=2-s2.0-33746414427&partnerID=40&md5=93faf90a947264606d5c965d8c74a3d3."},{"key":"290_CR16","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","volume":"88","author":"MJ Page","year":"2021","unstructured":"Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906.","journal-title":"Int J Surg"},{"key":"290_CR17","unstructured":"Wells GA et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000."},{"issue":"1","key":"290_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1210\/jcem.84.1.5382","volume":"84","author":"A Govind","year":"1999","unstructured":"Govind A, Obhrai MS, Clayton RN. Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. J Clin Endocrinol Metab. 1999;84(1):38\u201343. https:\/\/doi.org\/10.1210\/jcem.84.1.5382. in eng.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"290_CR19","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.2337\/dc07-2190","volume":"31","author":"S Sam","year":"2008","unstructured":"Sam S, Coviello AD, Sung YA, Legro RS, Dunaif A. \"Metabolic phenotype in the brothers of women with polycystic ovary syndrome. Diabetes Care. 2008;31(6):1237\u201341. https:\/\/doi.org\/10.2337\/dc07-2190. in eng.","journal-title":"Diabetes Care"},{"issue":"1","key":"290_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.metabol.2007.08.010","volume":"57","author":"S Sam","year":"2008","unstructured":"Sam S, Sung YA, Legro RS, Dunaif A. Evidence for pancreatic \u03b2-cell dysfunction in brothers of women with polycystic ovary syndrome. Metabolism. 2008;57(1):84\u20139. https:\/\/doi.org\/10.1016\/j.metabol.2007.08.010. in eng.","journal-title":"Metabolism"},{"issue":"1","key":"290_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.fertnstert.2016.03.029","volume":"106","author":"LC Torchen","year":"2016","unstructured":"Torchen LC, et al. Increased antim\u00fcllerian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome. Fertil Steril. 2016;106(1):50\u20135. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.03.029. in eng.","journal-title":"Fertil Steril"},{"issue":"6","key":"290_CR22","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1080\/01443610701497520","volume":"27","author":"A Hunter","year":"2007","unstructured":"Hunter A, Vimplis S, Sharma A, Eid N, Atiomo W. To determine whether first-degree male relatives of women with polycystic ovary syndrome are at higher risk of developing cardiovascular disease and type II diabetes mellitus. J Obstet Gynaecol. 2007;27(6):591\u20136. https:\/\/doi.org\/10.1080\/01443610701497520. in eng.","journal-title":"J Obstet Gynaecol"},{"issue":"11","key":"290_CR23","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1210\/jc.2009-1333","volume":"94","author":"AD Coviello","year":"2009","unstructured":"Coviello AD, Sam S, Legro RS, Dunaif A. High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity. J Clin Endocrinol Metab. 2009;94(11):4361\u20136. https:\/\/doi.org\/10.1210\/jc.2009-1333.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"290_CR24","first-page":"165","volume":"20","author":"A Lenarcik","year":"2011","unstructured":"Lenarcik A, Bidzi\u0144ska-Speichert B, Tworowska-Bardzi\u0144ska U. Metabolic abnormalities in siblings of women with polycystic ovary syndrome. Adv Clin Exp Med. 2011;20(2):165\u201375.","journal-title":"Adv Clin Exp Med"},{"key":"290_CR25","unstructured":"Lenarcik A, Bidzi\u0144ska-Speichert B, Tworowska-Bardzi\u0144ska U, Kr\u0229pu\u0142a K. Hormonal abnormalities in first-degree relatives of women with polycystic ovary syndrome (PCOS). Endokrynologia Polska. 2011;62(2):129\u2013133. [Online]. Available: https:\/\/www.scopus.com\/inward\/record.uri?eid=2-s2.0-79957991624&partnerID=40&md5=a1f124db3e3a840295d206c5443fb800."},{"issue":"5","key":"290_CR26","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1210\/jc.2002-021499","volume":"88","author":"BO Yildiz","year":"2003","unstructured":"Yildiz BO, Yarali H, Oguz H, Bayraktar M. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88(5):2031\u20136. https:\/\/doi.org\/10.1210\/jc.2002-021499. in eng.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"290_CR27","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1093\/humrep\/deu282","volume":"29","author":"DM Liu","year":"2014","unstructured":"Liu DM, et al. Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome. Hum Reprod. 2014;29(12):2764\u201372. https:\/\/doi.org\/10.1093\/humrep\/deu282.","journal-title":"Hum Reprod"},{"issue":"5","key":"290_CR28","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1210\/jcem.87.5.8387","volume":"87","author":"RS Legro","year":"2002","unstructured":"Legro RS, Kunselman AR, Demers L, Wang SC, Bentley-Lewis R, Dunaif A. Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87(5):2134\u20138. https:\/\/doi.org\/10.1210\/jcem.87.5.8387.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"290_CR29","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1210\/jc.2009-1849","volume":"95","author":"RS Legro","year":"2010","unstructured":"Legro RS, Roller RL, Dodson WC, Stetter CM, Kunselman AR, Dunaif A. Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives. J Clin Endocrinol Metab. 2010;95(2):789\u201399. https:\/\/doi.org\/10.1210\/jc.2009-1849. in eng.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"290_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000293493","volume":"28","author":"O Lunde","year":"1989","unstructured":"Lunde O, Magnus P, Sandvik L, H\u00f8glo S. Familial clustering in the polycystic ovarian syndrome. Gynecol Obstet Invest. 1989;28(1):23\u201330. https:\/\/doi.org\/10.1159\/000293493. in eng.","journal-title":"Gynecol Obstet Invest"},{"issue":"10","key":"290_CR31","doi-asserted-by":"publisher","first-page":"e25947","DOI":"10.1371\/journal.pone.0025947","volume":"6","author":"MJ Davies","year":"2011","unstructured":"Davies MJ, Marino JL, Willson KJ, March WA, Moore VM. Intergenerational associations of chronic disease and polycystic ovary syndrome. PLoS One. 2011;6(10):e25947. https:\/\/doi.org\/10.1371\/journal.pone.0025947. in eng.","journal-title":"PLoS One"},{"key":"290_CR32","unstructured":"Moradi F, Akbarzadeh MA, Dabbaghmaneh MH, Jafari PE, Parsanezhad ME. Prevalence of metabolic syndrome in fathers of patients with polycystic ovarian syndrome,\" Koomesh. 2010;Article 11(3):221\u2013230. [Online]. Available: https:\/\/www.scopus.com\/inward\/record.uri?eid=2-s2.0-77950806332&partnerID=40&md5=2b78b4a04ef37305fc7dda7538e49dce."},{"issue":"7","key":"290_CR33","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/09513590.2019.1566451","volume":"35","author":"K Subramaniam","year":"2019","unstructured":"Subramaniam K, Tripathi A, Dabadghao P. Familial clustering of metabolic phenotype in brothers of women with polycystic ovary syndrome. Gynecol Endocrinol. 2019;35(7):601\u20133. https:\/\/doi.org\/10.1080\/09513590.2019.1566451. in eng.","journal-title":"Gynecol Endocrinol"},{"issue":"9","key":"290_CR34","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/jcph.1872","volume":"61","author":"R Krysiak","year":"2021","unstructured":"Krysiak R, Basiak M, Szkr\u00f3bka W, Okopie\u0144 B. The impact of Telmisartan on cardiometabolic risk factors in hypertensive male siblings of women with Polycystic Ovary Syndrome. J Clin Pharmacol. 2021;61(9):1165\u201373. https:\/\/doi.org\/10.1002\/jcph.1872.","journal-title":"J Clin Pharmacol"},{"issue":"8","key":"290_CR35","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1093\/humrep\/der101","volume":"26","author":"MC Taylor","year":"2011","unstructured":"Taylor MC, Reema Kar A, Kunselman AR, Stetter CM, Dunaif A, Legro RS. Evidence for increased cardiovascular events in the fathers but not mothers of women with polycystic ovary syndrome. Hum Reprod. 2011;26(8):2226\u201331. https:\/\/doi.org\/10.1093\/humrep\/der101. in eng.","journal-title":"Hum Reprod"},{"issue":"5","key":"290_CR36","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.fertnstert.2016.01.024","volume":"105","author":"VP Vipin","year":"2016","unstructured":"Vipin VP, Dabadghao P, Shukla M, Kapoor A, Raghuvanshi AS, Ramesh V. Cardiovascular disease risk in first-degree relatives of women with polycystic ovary syndrome. Fertil Steril. 2016;105(5):1338-1344.e3. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.01.024. in eng.","journal-title":"Fertil Steril"},{"issue":"1","key":"290_CR37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.metabol.2008.08.007","volume":"58","author":"MC Villeneuve","year":"2009","unstructured":"Villeneuve MC, Ostlund RE Jr., Baillargeon JP. Hyperinsulinemia is closely related to low urinary clearance of d-chiro-inositol in men with a wide range of insulin sensitivity. Metabolism. 2009;58(1):62\u20138. https:\/\/doi.org\/10.1016\/j.metabol.2008.08.007. in eng.","journal-title":"Metabolism"},{"issue":"12","key":"290_CR38","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1007\/s00125-007-0831-9","volume":"50","author":"JP Baillargeon","year":"2007","unstructured":"Baillargeon JP, Carpentier AC. Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects. Diabetologia. 2007;50(12):2424\u201332. https:\/\/doi.org\/10.1007\/s00125-007-0831-9.","journal-title":"Diabetologia"},{"key":"290_CR39","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions, version 6.5 (updated August 2024). Cochrane, 2024. Available from www.cochrane.org\/handbook ."},{"issue":"9","key":"290_CR40","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3109\/09513590.2010.520375","volume":"27","author":"A Torvinen","year":"2011","unstructured":"Torvinen A, et al. Metabolic and reproductive characteristics of first-degree relatives of women with self-reported oligo-amenorrhoea and hirsutism. Gynecol Endocrinol. 2011;27(9):630\u20135. https:\/\/doi.org\/10.3109\/09513590.2010.520375.","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"290_CR41","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.fertnstert.2017.10.018","volume":"109","author":"B Yilmaz","year":"2018","unstructured":"Yilmaz B, Vellanki P, Ata B, Yildiz BO. Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Steril. 2018;109(2):356-364.e32. https:\/\/doi.org\/10.1016\/j.fertnstert.2017.10.018. in eng.","journal-title":"Fertil Steril"},{"key":"290_CR42","doi-asserted-by":"publisher","unstructured":"Kollmann M et al. Androgen and Anti-Mullerian Hormone Concentrations at Term in Newborns and Their Mothers with and without Polycystic Ovary Syndrome. J Clin Med. 2019;8(11). https:\/\/doi.org\/10.3390\/jcm8111817. in eng.","DOI":"10.3390\/jcm8111817"},{"issue":"5","key":"290_CR43","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1359\/jbmr.2001.16.5.911","volume":"16","author":"JM Zmuda","year":"2001","unstructured":"Zmuda JM, Cauley JA, Kuller LH, Ferrell RE. A common promoter variant in the cytochrome P450c17\u03b1 (CYP17) gene is associated with bioavailable testosterone levels and bone size in men. J Bone Miner Res. 2001;16(5):911\u20137. https:\/\/doi.org\/10.1359\/jbmr.2001.16.5.911.","journal-title":"J Bone Miner Res"},{"issue":"12","key":"290_CR44","doi-asserted-by":"publisher","first-page":"R305","DOI":"10.1530\/ec-21-0327","volume":"10","author":"X Liu","year":"2021","unstructured":"Liu X, Xu M, Qian M, Yang L. CYP17 T\/C (rs74357) gene polymorphism contributes to polycystic ovary syndrome susceptibility: evidence from a meta-analysis. Endocr Connect. 2021;10(12):R305-r316. https:\/\/doi.org\/10.1530\/ec-21-0327. in eng.","journal-title":"Endocr Connect"},{"issue":"5","key":"290_CR45","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/ng.120","volume":"40","author":"E Zeggini","year":"2008","unstructured":"Zeggini E, et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008;40(5):638\u201345. https:\/\/doi.org\/10.1038\/ng.120. in eng.","journal-title":"Nat Genet"},{"issue":"2","key":"290_CR46","first-page":"98","volume":"18","author":"M Akbarzadeh","year":"2013","unstructured":"Akbarzadeh M, Moradi F, Dabbaghmanesh M, Jafari P, Parsanezhad M. A survey of metabolic syndrome in first-degree relatives (fathers) of patients with polycystic ovarian syndrome. J Endocrinol Metab Diabetes S Afr. 2013;18(2):98\u2013103.","journal-title":"J Endocrinol Metab Diabetes S Afr"},{"issue":"6","key":"290_CR47","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1210\/jc.2005-1494","volume":"91","author":"JM Vink","year":"2006","unstructured":"Vink JM, Sadrzadeh S, Lambalk CB, Boomsma DI. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab. 2006;91(6):2100\u20134. https:\/\/doi.org\/10.1210\/jc.2005-1494.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"290_CR48","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/ng.2384","volume":"44","author":"Y Shi","year":"2012","unstructured":"Shi Y, et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet. 2012;44(9):1020\u20135. https:\/\/doi.org\/10.1038\/ng.2384.","journal-title":"Nat Genet"},{"issue":"2","key":"290_CR49","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s0738-081x(00)00125-5","volume":"19","author":"JA Ellis","year":"2001","unstructured":"Ellis JA, Harrap SB. The genetics of androgenetic alopecia. Clin Dermatol. 2001;19(2):149\u201354. https:\/\/doi.org\/10.1016\/s0738-081x(00)00125-5. in eng.","journal-title":"Clin Dermatol"},{"issue":"4","key":"290_CR50","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ijwd.2019.05.010","volume":"5","author":"PF Coogan","year":"2019","unstructured":"Coogan PF, et al. Association of type 2 diabetes with central-scalp hair loss in a large cohort study of African American women. Int J Womens Dermatol. 2019;5(4):261\u20136. https:\/\/doi.org\/10.1016\/j.ijwd.2019.05.010.","journal-title":"Int J Womens Dermatol"},{"issue":"1","key":"290_CR51","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.gene.2016.07.067","volume":"593","author":"MS Jahromi","year":"2016","unstructured":"Jahromi MS, Tehrani FR, Noroozzadeh M, Zarkesh M, Ghasemi A, Zadeh-Vakili A. Elevated expression of steroidogenesis pathway genes; CYP17, GATA6 and StAR in prenatally androgenized rats. Gene. 2016;593(1):167\u201371. https:\/\/doi.org\/10.1016\/j.gene.2016.07.067. in eng.","journal-title":"Gene"},{"issue":"3","key":"290_CR52","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/1097-0215(20000801)87:3<434::aid-ijc19>3.0.co;2-g","volume":"87","author":"A Gsur","year":"2000","unstructured":"Gsur A, et al. A polymorphism in the CYP17 gene is associated with prostate cancer risk. Int J Cancer. 2000;87(3):434\u20137. https:\/\/doi.org\/10.1002\/1097-0215(20000801)87:3%3c434::aid-ijc19%3e3.0.co;2-g. in eng.","journal-title":"Int J Cancer"},{"issue":"3","key":"290_CR53","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.taap.2013.01.033","volume":"268","author":"MJ Roelofs","year":"2013","unstructured":"Roelofs MJ, Piersma AH, van den Berg M, van Duursen MB. The relevance of chemical interactions with CYP17 enzyme activity: assessment using a novel in vitro assay. Toxicol Appl Pharmacol. 2013;268(3):309\u201317. https:\/\/doi.org\/10.1016\/j.taap.2013.01.033. in eng.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"5","key":"290_CR54","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00404-016-4159-x","volume":"294","author":"J Gao","year":"2016","unstructured":"Gao J, Xue J-D, Li Z-C, Zhou L, Chen C. The association of DENND1A gene polymorphisms and polycystic ovary syndrome risk: a systematic review and meta-analysis. Arch Gynecol Obstet. 2016;294(5):1073\u201380. https:\/\/doi.org\/10.1007\/s00404-016-4159-x.","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"290_CR55","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1136\/jmedgenet-2011-100727","volume":"49","author":"T Li","year":"2012","unstructured":"Li T, et al. Identification of YAP1 as a novel susceptibility gene for polycystic ovary syndrome. J Med Genet. 2012;49(4):254\u20137. https:\/\/doi.org\/10.1136\/jmedgenet-2011-100727. in eng.","journal-title":"J Med Genet"},{"key":"290_CR56","doi-asserted-by":"publisher","first-page":"147062","DOI":"10.1016\/j.gene.2022.147062","volume":"852","author":"RA Harris","year":"2023","unstructured":"Harris RA, et al. Loci on chromosome 12q13.2 encompassing ERBB3, PA2G4 and RAB5B are associated with polycystic ovary syndrome. Gene. 2023;852:147062. https:\/\/doi.org\/10.1016\/j.gene.2022.147062. in eng.","journal-title":"Gene"},{"key":"290_CR57","doi-asserted-by":"publisher","unstructured":"Joshi-Tope G et al. Reactome: a knowledgebase of biological pathways. Nucleic Acids Res. 2005;33(Database issue):D428\u201332.\u00a0https:\/\/doi.org\/10.1093\/nar\/gki072.\u00a0in eng.","DOI":"10.1093\/nar\/gki072"},{"key":"290_CR58","doi-asserted-by":"publisher","unstructured":"Matthews L et al. Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res. 2009;37(Database issue):D619\u201322 in eng. https:\/\/doi.org\/10.1093\/nar\/gkn863.","DOI":"10.1093\/nar\/gkn863"},{"issue":"1","key":"290_CR59","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.abb.2006.01.020","volume":"449","author":"CM Hunker","year":"2006","unstructured":"Hunker CM, Kruk I, Hall J, Giambini H, Veisaga ML, Barbieri MA. Role of Rab5 in insulin receptor-mediated endocytosis and signaling. Arch Biochem Biophys. 2006;449(1):130\u201342. https:\/\/doi.org\/10.1016\/j.abb.2006.01.020.","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"290_CR60","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.fertnstert.2018.04.024","volume":"110","author":"B Yilmaz","year":"2018","unstructured":"Yilmaz B, Vellanki P, Ata B, Yildiz BO. Diabetes mellitus and insulin resistance in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Steril. 2018;110(3):523-533.e14. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.04.024. in eng.","journal-title":"Fertil Steril"},{"issue":"1","key":"290_CR61","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/clinem\/dgab640","volume":"107","author":"D Shan","year":"2022","unstructured":"Shan D, Han J, Cai Y, Zou L, Xu L, Shen Y. Reproductive health in first-degree relatives of patients with polycystic ovary syndrome: a review and meta-analysis. J Clin Endocrinol Metab. 2022;107(1):273\u201395. https:\/\/doi.org\/10.1210\/clinem\/dgab640. in eng.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"290_CR62","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/humupd\/dmz036","volume":"26","author":"MN Gunning","year":"2020","unstructured":"Gunning MN, et al. Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis. Hum Reprod Update. 2020;26(1):103\u201317. https:\/\/doi.org\/10.1093\/humupd\/dmz036. in eng.","journal-title":"Hum Reprod Update"},{"issue":"11","key":"290_CR63","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1007\/s40618-024-02374-7","volume":"47","author":"M Noroozzadeh","year":"2024","unstructured":"Noroozzadeh M, Rahmati M, Amiri M, Saei Ghare Naz M, Azizi F, Ramezani Tehrani F. Preconceptional maternal hyperandrogenism and metabolic syndrome risk in male offspring: a long-term population-based study. J Endocrinol Invest. 2024;47(11):2731\u201343. https:\/\/doi.org\/10.1007\/s40618-024-02374-7. in eng.","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"290_CR64","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/s40618-022-01972-7","volume":"46","author":"M Farhadi-Azar","year":"2023","unstructured":"Farhadi-Azar M, et al. Maternal androgen excess increases the risk of pre-diabetes mellitus in male offspring in later life: a long-term population-based follow-up study. J Endocrinol Invest. 2023;46(9):1775\u201385. https:\/\/doi.org\/10.1007\/s40618-022-01972-7. in eng.","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"290_CR65","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s00404-023-07132-3","volume":"308","author":"M Noroozzadeh","year":"2023","unstructured":"Noroozzadeh M, Rahmati M, Farhadi-Azar M, Saei Ghare Naz M, Azizi F, Ramezani Tehrani F. Maternal androgen excess increases the risk of metabolic syndrome in female offspring in their later life: a long-term population-based follow-up study. Arch Gynecol Obstet. 2023;308(5):1555\u201366. https:\/\/doi.org\/10.1007\/s00404-023-07132-3. in eng.","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"290_CR66","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s40618-021-01721-2","volume":"45","author":"M Noroozzadeh","year":"2022","unstructured":"Noroozzadeh M, Rahmati M, Behboudi-Gandevani S, Ramezani Tehrani F. Maternal hyperandrogenism is associated with a higher risk of type 2 diabetes mellitus and overweight in adolescent and adult female offspring: a long-term population-based follow-up study. J Endocrinol Invest. 2022;45(5):963\u201372. https:\/\/doi.org\/10.1007\/s40618-021-01721-2. in eng.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"290_CR67","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1365-2605.2009.00953.x","volume":"33","author":"H V\u00f6lzke","year":"2010","unstructured":"V\u00f6lzke H, et al. Hepatic steatosis is associated with low serum testosterone and high serum DHEAS levels in men. Int J Androl. 2010;33(1):45\u201353. https:\/\/doi.org\/10.1111\/j.1365-2605.2009.00953.x.","journal-title":"Int J Androl"},{"issue":"5","key":"290_CR68","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1046\/j.1365-2230.2002.01086.x","volume":"27","author":"R Hoffmann","year":"2002","unstructured":"Hoffmann R. Male androgenetic alopecia. Clin Exp Dermatol. 2002;27(5):373\u201382. https:\/\/doi.org\/10.1046\/j.1365-2230.2002.01086.x. in eng.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"290_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/eje.0.1510001","volume":"151","author":"A Tchernof","year":"2004","unstructured":"Tchernof A, Labrie F. Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies. Eur J Endocrinol. 2004;151(1):1\u201314. https:\/\/doi.org\/10.1530\/eje.0.1510001.","journal-title":"Eur J Endocrinol"}],"container-title":["Basic and Clinical Andrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12610-025-00290-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12610-025-00290-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12610-025-00290-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:06:24Z","timestamp":1763424384000},"score":1,"resource":{"primary":{"URL":"https:\/\/bacandrology.biomedcentral.com\/articles\/10.1186\/s12610-025-00290-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,16]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["290"],"URL":"https:\/\/doi.org\/10.1186\/s12610-025-00290-1","relation":{},"ISSN":["2051-4190"],"issn-type":[{"value":"2051-4190","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,16]]},"assertion":[{"value":"29 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The proposal for this research has been approved by the Ethics Committee of Infertility and Reproductive Health Research Center (IRHRC), Shahid Beheshti University of Medical Sciences\u00a0(IR.SBMU.ENDOCRINE.REC.1403.146).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}